NCT02637232已完成不适用
Mirvaso® Utilisation and Patient Satisfaction Evaluation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Galderma R&D
- 入组人数
- 301
- 试验地点
- 1
- 主要终点
- Satisfaction Among Patients to Whom Mirvaso®/OnrelteaTM is Prescribed Question
研究概览
简要总结
The aim of the study is to evaluate the level of satisfaction among patients to whom Mirvaso® / Onreltea TM (trade mark) is prescribed.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients to whom the physician has already decided to prescribe Mirvaso® /OnrelteaTM according to package insert
排除标准
- 未提供
结局指标
主要结局
Satisfaction Among Patients to Whom Mirvaso®/OnrelteaTM is Prescribed Question
时间窗: Week 4
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.Overactive BladderNCT02468375Samsung Medical Center434
已完成
4 期
Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi PrepColorectal CancerNCT01695863Rush University Medical Center150
已完成
不适用
Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual BleedingMenorrhagiaNCT00874653Bayer78
已完成
不适用
Xarelto [SPAF-QOL] Post-marketing Surveillance in JapanNon-valvular Atrial Fibrillation (NVAF)NCT01598051Bayer741
已完成
不适用
Vivity Insight: A Study of Patient Satisfaction and Visual PerformanceCataractNCT04495049Research Insight LLC60